Cicatrizing Blepharoconjunctivitis Occurring During Dupilumab Treatment and a Proposed Algorithm for Its Management-Reference-Cited by-同舟云学术

Cicatrizing Blepharoconjunctivitis Occurring During Dupilumab Treatment and a Proposed Algorithm for Its Management

Published:2018-12-01 Issue:12 Volume:154 Page:1485
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Levine Russell M.¹,Tattersall Ian W.²,Gaudio Paul A.³⁴,King Brett A.²

Affiliation:

1. Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut

2. Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut

3. Department of Ophthalmology, Hartford Hospital, Hartford, Connecticut

4. Connecticut Uveitis Foundation, West Hartford

Publisher

American Medical Association (AMA)

Subject

Dermatology

Reference6 articles.

1. An update on the pathophysiology of atopic dermatitis.;Malik;Dermatol Clin,2017

2. Atopic keratoconjunctivitis: a review.;Chen;J Am Acad Dermatol,2014

3. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.;Blauvelt;Lancet,2017

4. Cicatricial ectropion in a patient treated with dupilumab.;Barnes;Am J Ophthalmol Case Rep,2017

5. Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment.;Wollenberg;J Allergy Clin Immunol Pract,2018

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral ulcerative keratitis associated with tralokinumab therapy: a case report and review of IL-13 inhibitor-associated ocular surface disease;Journal of Ophthalmic Inflammation and Infection;2024-04-16

2. A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis;Dermatitis®;2024-02-01

3. Podcast on Cross-speciality Perspectives on Practical Management of Atopic Dermatitis-Associated Ocular Surface Diseases;Dermatology and Therapy;2024-02

4. Peripheral Ulcerative Keratitis Associated with Tralokinumab Therapy: A Case Report and Review of IL-13 Inhibitor-Associated Ocular Surface Disease;2024-01-02

5. Ocular Surface Adverse Events are not Associated with Dupilumab use in Nasal Polyp Treatment;The Laryngoscope;2023-12